The Journal of Immunology, Vol 156, Issue 5 1735-1742, Copyright © 1996 by American Association of Immunologists

ARTICLES

Biochemical characterization of antigen-specific glycosylation- inhibiting factor from antigen-specific suppressor T cells. II. The 55- kDa glycosylation-inhibiting factor peptide is a derivative of TCR alpha-chain and a subunit of antigen-specific glycosylation-inhibiting factor

Y Ishii, T Nakano and K Ishizaka
Division of Immunology, La Jolla Institute for Allergy and Immunology, CA 92037, USA.

We isolated a unique TCR alpha-chain derived from the OVA-specific Ts hybridoma, 231F1. The TR alpha-chain consists of V alpha 11.3, a unique J alpha and a complete sequence of C alpha region. Transfection of the TCR-alpha cDNA into a TCR-alpha-, TCR-beta+ T cell line, 175.2, resulted in the expression of TCR-alpha beta, and the transfectant contained a 35-kDa peptide having the TCR- alpha-specific antigenic determinant. However, the stable transfectant failed to release a peptide with the TCR-alpha determinant upon stimulation with anti-CD3. In contrast, overexpression of the cDNA in the 231 F1 cells markedly increased the formation of the 55-kDa peptide, which reacted with both anti-glycosylation-inhibiting factor (GIF) and the mAb H28-710. Definitive evidence for the relationship between the 55-kDa peptide and the TCR alpha-chain was obtained by transfection of the cDNA of the TCR alpha-chain with histidine tag into the 231F1 cells. The 55 kDa GIF peptide formed by stable transfectants of the TCR-alpha-tag cDNA bound to Ni+-nitrilotriacetic acid-agarose. Upon stimulation with anti-CD3, a stable transfectant of the TCR-alpha cDNA formed OVA-specific GIF which contained the 55-kDa GIF peptide, and bound not only to anti-TCR-alpha column but also to anti-TCR-beta column. The results indicate that the OVA-specific GIF consists of the TCR-alpha+ 55-kDa GIF and another peptide with TCR-beta determinant. It was found that the association of the TCR-beta+ peptide with the 55-kDa GIF is required for binding of the factor to OVA, but not essential for the formation and release of the latter peptide.

This article has been cited by other articles:

				H. Watarai, R. Nozawa, A. Tokunaga, N. Yuyama, M. Tomas, A. Hinohara, K. Ishizaka, and Y. Ishii Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF PNAS, November 2, 2000; (2000) 230445397. [Abstract] [Full Text]

				H. Maeda, S. Fujimoto, and M. I. Greene Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vbeta 8.1 transgenic mice PNAS, November 2, 2000; (2000) 230449097. [Abstract] [Full Text]

				C. H. Little, G. M. Georgiou, G. Fey, B. Ravindran, J. Levine, H. Ogedegbe, H. Yamase, and R. E. Cone Detection of Antigen-Specific Human Serum Proteins Related to the T-Cell Receptor in Infectious Disease and in an Immune Response to Milk Proteins or Chemicals Experimental Biology and Medicine, September 1, 2000; 224(4): 264 - 272. [Abstract] [Full Text]

				K. Kasahara, T. Nakano, H. Takahashi, Y. Ishii, K. Ishizaka, and K. Imai Presence of the 55 kDa glycosylation inhibiting factor in human serum Int. Immunol., September 1, 2000; 12(9): 1303 - 1309. [Abstract] [Full Text] [PDF]

				K. Sugie, T. Tomura, K. Takakura, T. Kawano, M. Taniguchi, H. M. Grey, and K. Ishizaka Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor Int. Immunol., July 1, 1999; 11(7): 1149 - 1156. [Abstract] [Full Text] [PDF]

				T. Tomura, H. Watarai, N. Honma, M. Sato, A. Iwamatsu, Y. Kato, R. Kuroki, T. Nakano, T. Mikayama, and K. Ishizaka Immunosuppressive Activities of Recombinant Glycosylation -Inhibiting Factor Mutants J. Immunol., January 1, 1999; 162(1): 195 - 202. [Abstract] [Full Text] [PDF]

				K. Sugie, T. Nakano, T. Tomura, K. Takakura, T. Mikayama, and K. Ishizaka High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells PNAS, May 13, 1997; 94(10): 5278 - 5283. [Abstract] [Full Text] [PDF]

				T. Nakano, H. Watarai, Y.-C. Liu, Y. Oyama, T. Mikayama, and K. Ishizaka Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group PNAS, January 7, 1997; 94(1): 202 - 207. [Abstract] [Full Text] [PDF]

				H. Watarai, R. Nozawa, A. Tokunaga, N. Yuyama, M. Tomas, A. Hinohara, K. Ishizaka, and Y. Ishii Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF PNAS, November 21, 2000; 97(24): 13251 - 13256. [Abstract] [Full Text] [PDF]

				H. Maeda, S. Fujimoto, and M. I. Greene Suppressor T cells regulate the nonanergic cell population that remains after peripheral tolerance is induced to the Mls-1 antigen in T cell receptor Vbeta 8.1 transgenic mice PNAS, November 21, 2000; 97(24): 13257 - 13262. [Abstract] [Full Text] [PDF]